FDA flags health risks from ‘Benadryl Challenge’

TIK TOK Social media app’s insane challenge puts it as emergent health concern that we all should know about the results if the challenge can be dramatic

Teen misuse sparked by dangerous “Benadryl Challenge” promoted on social media

The U.S. Food and Drug Administration (FDA) is warning that consumers should not take higher than the recommended dose of the common over-the-counter (OTC) allergy medicine Benadryl due to highly penitential risk that could lead to serious heart problems, seizures, coma, or death. ‘Benadryl Challenge’ is trending on TIK TOK resulting in news reports of teenagers ending up in emergency rooms or dying after participating in the “Benadryl Challenge” encouraged in videos posted on the social media app TIK TOC

The Benadryl Challenge on Tik-Tok involves trying to get high off the antihistamine. Teenagers are taking large amounts of Benadryl to “trip” on the medication in hopes of getting high and having hallucinations.

Consumers, parents, and caregivers should store diphenhydramine the generic name for Benadryl and all other OTC and prescription medicines up and away and out of children’s reach and sight. The FDA recommends you lock up medicines to prevent accidental poisonings by children and misuse by teens, especially when they are home more often due to the recent social restrictions and may be more likely to experiment. Call poison control at 1-800-222-1222 if you or anyone else has further question’s concerning the potential dangers.

U.S. reverses COVID-19 testing guidance

U.S. reverses COVID-19 testing guidance again. Exposed people non-symptomatic need to be tested regardless

In other words, so many people can “be host carriers.” They had or have the virus without knowing it and likely could cause many others to contract COVID19. Host carriers play major factor in the spread of the virus-Kaleidoscope Thought by Amy

The Trump administration reversed guidance Friday 09-25-2020 on COVID-19 testing for a second time, urging those exposed to people with the virus to get tested even if they are not symptomatic.

The changes that were made can be located at the following link https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html

For More Info
855-543-DRUG (3784) and press 4
druginfo@fda.hhs.gov

Report a Serious Problem to MedWatch

MedWatch

MedWatch is the Food and Drug Administration’s “Safety Information and Adverse Event Reporting Program.” It interacts with the FDA Adverse Event Reporting System. MedWatch is used for reporting an adverse event or sentinel event. Founded in 1993, this system of voluntary reporting allows such information to be shared with the medical community or the general public. The system includes publicly available databases and online analysis tools for professionals. MedWatch also distributes information on medical recalls and other clinical safety communications via its platforms.